Anthem Blue Cross Blue Shield of California prior authorization, page 59

CPT code lookup

Each row is one code from the public prior authorization list. The description is the procedure or service name on that source row. This is not a coverage decision.

Prior authorization codes

Prior authorization codes
CodeDescriptionSource
0582URare diseases (constitutional disease/hereditary disorders), rapid whole genome DNA sequencing for single nucleotide variants, insertions/deletions, copy number variations, blood, saliva, tissue sample, variants reportedCalifornia PPO Prior Authorization List, Pg 154 Original policy
0583URare diseases (constitutional disease/hereditary disorders), rapid whole genome comparator DNA sequencing for single- nucleotide variants, insertions/deletions, copy number variations, blood, saliva, tissue sample, variants reported with proband resultsCalifornia PPO Prior Authorization List, Pg 154 Original policy
0586UOncology, mRNA, gene expression profiling of 216 genes (204 targeted and 12 housekeeping genes), RNA expression analysis, formalin-fixed paraffin-embedded (FFPE) tissue, quantitative, reported as log2 ratio per geneCalifornia PPO Prior Authorization List, Pg 154 Original policy
0592UOncology (hematolymphoid neoplasms), DNA, targeted genomic sequence of 417 genes, interrogation for gene fusions, translocations, rearrangements, utilizing formalin- fixed paraffin-embedded (FFPE) tumor tissue, results report clinically significant variant(s)California PPO Prior Authorization List, Pg 154 Original policy
0597UOncology (breast), RNA expression profiling of 329 genes by targeted nextgeneration sequencing and 20 proteins by multiplex immunofluorescence, formalin-fixed paraffin- embedded (FFPE) tissue, algorithmic analyses to determine tumor-recurrence risk scoreCalifornia PPO Prior Authorization List, Pg 154 Original policy
0605UAllergy and immunology (hereditary alpha tryptasemia), DNA, analysis of TPSAB1 gene copy number variation using digital PCR, whole blood, results reported with genotype specific interpretation of alpha-tryptase copy number and algorithmic classification as normal or abnormalCalifornia PPO Prior Authorization List, Pg 154 Original policy
0611UOncology (liver), analysis of over 1,000 methylated regions, cell-free DNA from plasma, algorithm reported as a quantitative resultCalifornia PPO Prior Authorization List, Pg 155 Original policy
0612UOncology (liver), analysis of over 1,000 methylated regions, cell-free DNA from plasma, algorithm reported as a quantitative resultCalifornia PPO Prior Authorization List, Pg 155 Original policy
0613UOncology (urothelial carcinoma), DNA methylation and mutation analysis of 6 biomarkers (TWIST1, OTX1, ONECUT2, FGFR3, HRAS, TERT promoter region), methylation-specific PCR and targeted next-generation sequencing, urine, algorithm reported as a probability index for bladder cancer and upper tract urothelial carcinomaCalifornia PPO Prior Authorization List, Pg 155 Original policy
0628UNephrology (kidney disease-related genetic conditions), genomic analysis, renal disease panel, saliva, DNA, next- generation sequencing of 449 genes, reported as pathogenic or likely pathogenic variants of uncertain significance or risk allelesCalifornia PPO Prior Authorization List, Pg 155 Original policy
0630UOncology (breast), mRNA, gene expression profiling by microarray of 80 genes (80 content and 465 housekeeping), utilizing formalin-fixed paraffin-embedded tissue (FFPE), algorithm reported as an index that is diagnostic of a molecular subtype (luminal, basal, Her2)California PPO Prior Authorization List, Pg 155 Original policy
A4544Electrode for external lower extremity nerve stimulator for restless legs syndromeCalifornia PPO Prior Authorization List, Pg 155 Original policy
A4545Supplies and accessories for external tibial nerve stimulator (e.g., socks, gel pads, electrodes, etc.), needed for one month [e.g., supplies for Vivally and ZIDA systems]California PPO Prior Authorization List, Pg 155 Original policy
A4604Tubing with heating elementCalifornia PPO Prior Authorization List, Pg 155 Original policy
A7027Combination Oral/Nasal Mask used with positive airway pressure device, eachCalifornia PPO Prior Authorization List, Pg 155 Original policy
A7028Oral Cushion, Replacement for Combination Oral/Nasal Mask, eachCalifornia PPO Prior Authorization List, Pg 155 Original policy
A7029Nasal Pillows, Replacement for Combination Oral/Nasal Mask, pairCalifornia PPO Prior Authorization List, Pg 155 Original policy
A7030Full Face Mask used with positive airway pressure device, eachCalifornia PPO Prior Authorization List, Pg 155 Original policy
A7031Face Mask Cushion, Replacement for Full Face MaskCalifornia PPO Prior Authorization List, Pg 155 Original policy
A7032Replacement Cushion for Nasal Application DeviceCalifornia PPO Prior Authorization List, Pg 155 Original policy
A7033Replacement Pillows for Nasal Application Device, pairCalifornia PPO Prior Authorization List, Pg 155 Original policy
A7034Nasal Interface (mask or cannula type), used with positive airway pressure device, with/without head strapCalifornia PPO Prior Authorization List, Pg 155 Original policy
A7035HeadgearCalifornia PPO Prior Authorization List, Pg 155 Original policy
A7036ChinstrapCalifornia PPO Prior Authorization List, Pg 155 Original policy
A7037TubingCalifornia PPO Prior Authorization List, Pg 156 Original policy
A7038Filter, disposableCalifornia PPO Prior Authorization List, Pg 156 Original policy
A7039Filter, non-disposableCalifornia PPO Prior Authorization List, Pg 156 Original policy
A7044Oral Interface for Positive Airway Pressure TherapyCalifornia PPO Prior Authorization List, Pg 156 Original policy
A7045Replacement Exhalation Port for PAP TherapyCalifornia PPO Prior Authorization List, Pg 156 Original policy
A7046Water chamber for humidifier, replacement, eachCalifornia PPO Prior Authorization List, Pg 156 Original policy
A9513Lutetium Lu 177, dotatate, therapeutic, 1 mCi (Lutathera)California PPO Prior Authorization List, Pg 156 Original policy
A9543Yttrium Y-90 ibritumomab tiuxetan, therapeutic, per treatment dose, up to 40mCi (Zevalin)California PPO Prior Authorization List, Pg 156 Original policy
A9552Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuriesCalifornia PPO Prior Authorization List, Pg 156 Original policy
A9586Florbetapir f18, diagnostic, per study dose, up to 10 millicuriesCalifornia PPO Prior Authorization List, Pg 156 Original policy
A9601Flortaucipir f 18 injection, diagnostic, 1 millicurieCalifornia PPO Prior Authorization List, Pg 156 Original policy
A9602Fluorodopa f-18, diagnostic, per millicurieCalifornia PPO Prior Authorization List, Pg 156 Original policy
A9606Radium ra-223 dichloride, therapeutic (Xofigo)California PPO Prior Authorization List, Pg 156 Original policy
A9515Choline c-11, diagnostic, per study dose up to 20 millicuriesCalifornia PPO Prior Authorization List, Pg 156 Original policy
A9580Sodium fluoride f-18, diagnostic, per study dose, up to 30 millicuriesCalifornia PPO Prior Authorization List, Pg 156 Original policy
A9587Gallium ga-68, dotatate, diagnostic, 0.1 millicurie (Gallium dotatate)California PPO Prior Authorization List, Pg 157 Original policy
A9588Fluciclovine f-18, diagnostic, 1 millicurie (Axumin)California PPO Prior Authorization List, Pg 157 Original policy
A9591Fluoroestradiol f 18, diagnostic, 1 millicurie (Cerianna)California PPO Prior Authorization List, Pg 157 Original policy
A9592Copper cu-64, dotatate, diagnostic, 1 millicurie (Copper dotatate)California PPO Prior Authorization List, Pg 157 Original policy
A9593Gallium ga-68 psma-11, diagnostic, (ucsf), 1 millicurie (PSMA)California PPO Prior Authorization List, Pg 157 Original policy
A9594Gallium ga-68 psma-11, diagnostic, (ucla), 1 millicurie (PSMA)California PPO Prior Authorization List, Pg 157 Original policy
A9595Piflufolastat f-18, diagnostic, 1 millicurie (Pylarify)California PPO Prior Authorization List, Pg 157 Original policy
A9596Gallium ga-68 gozetotide, diagnostic, (illuccix), 1 millicurie (Illuccix)California PPO Prior Authorization List, Pg 157 Original policy
A9597Positron emission tomography radiopharmaceutical, diagnostic, for tumor identification, NOCCalifornia PPO Prior Authorization List, Pg 157 Original policy
A9598Positron emission tomography radiopharmaceutical, diagnostic, for tumor identification, NOCCalifornia PPO Prior Authorization List, Pg 157 Original policy
A9608Flotufolastat f 18, diagnostic, 1 millicurie (Posluma)California PPO Prior Authorization List, Pg 157 Original policy

Sources

Disclaimer

The information provided on this page is for general informational purposes only and does not constitute billing, coding, or reimbursement advice. Nothing on this page should be relied upon as a substitute for clinician assessment, professional billing guidance, or as a definitive statement of any payor's billing requirements or policies.

Payor agreements, fee schedules, and billing policies vary and are subject to change. Before submitting any claims related to maternity care services, including claims affected by the 2027 CPT code revisions, please consult the applicable payor agreements, coverage policies, and billing guidelines to confirm current requirements for their specific payor contracts.

Substrate makes no representation or warranty regarding the accuracy, completeness, or timeliness of the payor-specific information presented here. Providers are solely responsible for ensuring that all claims are submitted in accordance with applicable payor requirements, and Substrate assumes no liability for claim denials, underpayments, or other adverse outcomes arising from reliance on this information.